Ovarian Cancer Rates On The Decline | Latest News RSS feed

Ovarian Cancer Rates On The Decline - Latest News

Ovarian Cancer Risk Factors and Symptoms

"It's important for women to be aware of the symptoms, as early diagnoses can improve survival rates." Dr. Chobanian says the following symptoms are early warning signs of ovarian cancer: *Persistent ... read more

Ovarian cancer rates on the decline

A new report from the American Cancer Society shows good news when it comes to ovarian cancer diagnoses. The report shows fewer women are being diagnosed with ovarian cancer. Ovarian cancer rates have ... read more

Ovarian Cancer Mortality Declining in United States, Europe

Ovarian cancer mortality rates declined significantly in several parts of the world from 2002 to 2012, according to a new study. Among the main reasons for the decline is the use of oral contraceptive... read more

Looking for another news?

Are Birth Control Pills Tied to Decline in Ovarian Cancer Deaths?

Japan has low rates of birth control use, the researchers said. Ovarian cancer death rates are expected to continue to decline 15 percent in the United States, and 10 percent in the European Union and ... read more

Deaths from ovarian cancer decline worldwide due to oral contraceptive use

In the USA the decline was even greater, with a 16% drop in death rates from 5.76 per 100,000 in 2002 to 4.85 in 2012. In Canada ovarian cancer death rates decreased over the same period by nearly 8% ... read more

Notre Dame cancer researchers publish new papers on ovarian cancer tumor growth

“The research we’re doing at Harper is leading us closer to answering questions unique to ovarian cancer,” Stack said. “This will eventually pave the way for more and better treatment options, with th... read more

News release far too rosy/conflicted for small study on ovarian cancer test

Ovarian cancer is common and often fatal. Symptoms often develop late, when the cancer is advanced and much more difficult to treat. Technologies that might facilitate earlier diagnosis could have a m... read more

Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails

Pfizer, Inc. (PFE - Free Report) and partner Merck KGaA announced that a late-stage study, evaluating their PD-L1 inhibitor, Bavencio (avelumab), in a difficult-to-treat advanced ovarian cancer patien... read more

Tesaro: In The Middle Of A Difficulty Is An Opportunity

An excellent place to search for bargain stocks is to assess equities that experienced a big decline subsequent ... because the death rate for advanced/resistant ovarian cancer is “off the ... read more

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Merck KGaA MKKGY, +2.36% and Pfizer Inc. PFE, +0.69% said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial ... 0.22% and a 1% de... read more

New blood test detects early stage ovarian cancer

"Ovarian cancer is notoriously difficult to detect in its early stages, when there are more options for treatment and survival rates are better. Our new test is therefore a potential game changer ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us